Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative contr...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2018-12-01
|
Series: | Bûlleten' Sibirskoj Mediciny |
Subjects: | |
Online Access: | https://bulletin.tomsk.ru/jour/article/view/1980 |
id |
doaj-a1a6fdc0404a45b8b52e373780497549 |
---|---|
record_format |
Article |
spelling |
doaj-a1a6fdc0404a45b8b52e3737804975492021-07-29T08:38:05ZengSiberian State Medical University (Tomsk)Bûlleten' Sibirskoj Mediciny1682-03631819-36842018-12-01174728410.20538/1682-0363-2018-4-72-841453Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graftE. V. Lebedeva0A. S. Gorokhov1E. D. Schastnyy2A. N. Repin3G. G. Simutkin4E. V. Shishneva5V. A. Perchatkin6A. K. Surovtseva7S. Winter8R. S. Karpov9N. A. Bokhan10Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS); Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Pediatrics Research Clinical Institute named after Аcademician Yu.E. Veltishchev of N.I. Pirogov, Russian National Research Moscow University (RNRMU)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)EVER Neuro Pharma GmbH OberburgauCardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS); Siberian State Medical University (SSMU) ; National Research Tomsk State University (NR TSU)Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative controlled parallel study included 60 men. The average age in the group of patients receiving the therapy with Cerebrolysin was 61.5 (57÷66) years, and was – 61 (56÷65) years (р > 0.05) in the comparison group.Results. Groups differed statistically significantly according to the left ventricular ejection fraction: 56 (48÷64) – in the group of comparison, 61 (59÷65) – in the group of patients receiving therapy with Cerebrolysin (p < 0.05). In the group of patients receiving Cerebrolysin, an increase in score according to MMSE (р < 0.01) was noted from 25 (24÷27) to 26.2 (24–28) points, and in the group without brain neuroprotection in the preoperative period a decrease in score according the Mini-Mental State Examination was revealed to be from 25.5 (25÷27) to 25 (23÷27) (р < 0.01). Clinical value of the level of protein S100ß as a biological indicator of postoperative cognitive dysfunction after cardiac surgery was ambiguous and required additional research.Conclusion. Brain neuroprotection with use of Cerebrolysin (authors’ schema) promoted not only maintenance but also improvement of cognitive functions and decreased the likelihood of complications in mental activity after coronary artery bypass graft surgery under conditions of artificial circulation and cold cardioplegia, particularly in patients with a high risk for their development.https://bulletin.tomsk.ru/jour/article/view/1980postoperative cognitive dysfunctioncoronary artery bypass graftprotein s100ßcerebrolysin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E. V. Lebedeva A. S. Gorokhov E. D. Schastnyy A. N. Repin G. G. Simutkin E. V. Shishneva V. A. Perchatkin A. K. Surovtseva S. Winter R. S. Karpov N. A. Bokhan |
spellingShingle |
E. V. Lebedeva A. S. Gorokhov E. D. Schastnyy A. N. Repin G. G. Simutkin E. V. Shishneva V. A. Perchatkin A. K. Surovtseva S. Winter R. S. Karpov N. A. Bokhan Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft Bûlleten' Sibirskoj Mediciny postoperative cognitive dysfunction coronary artery bypass graft protein s100ß cerebrolysin |
author_facet |
E. V. Lebedeva A. S. Gorokhov E. D. Schastnyy A. N. Repin G. G. Simutkin E. V. Shishneva V. A. Perchatkin A. K. Surovtseva S. Winter R. S. Karpov N. A. Bokhan |
author_sort |
E. V. Lebedeva |
title |
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft |
title_short |
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft |
title_full |
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft |
title_fullStr |
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft |
title_full_unstemmed |
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft |
title_sort |
time course of cognitive dysfunction and biochemical marker of cns lesions s100ß in coronary artery bypass graft |
publisher |
Siberian State Medical University (Tomsk) |
series |
Bûlleten' Sibirskoj Mediciny |
issn |
1682-0363 1819-3684 |
publishDate |
2018-12-01 |
description |
Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative controlled parallel study included 60 men. The average age in the group of patients receiving the therapy with Cerebrolysin was 61.5 (57÷66) years, and was – 61 (56÷65) years (р > 0.05) in the comparison group.Results. Groups differed statistically significantly according to the left ventricular ejection fraction: 56 (48÷64) – in the group of comparison, 61 (59÷65) – in the group of patients receiving therapy with Cerebrolysin (p < 0.05). In the group of patients receiving Cerebrolysin, an increase in score according to MMSE (р < 0.01) was noted from 25 (24÷27) to 26.2 (24–28) points, and in the group without brain neuroprotection in the preoperative period a decrease in score according the Mini-Mental State Examination was revealed to be from 25.5 (25÷27) to 25 (23÷27) (р < 0.01). Clinical value of the level of protein S100ß as a biological indicator of postoperative cognitive dysfunction after cardiac surgery was ambiguous and required additional research.Conclusion. Brain neuroprotection with use of Cerebrolysin (authors’ schema) promoted not only maintenance but also improvement of cognitive functions and decreased the likelihood of complications in mental activity after coronary artery bypass graft surgery under conditions of artificial circulation and cold cardioplegia, particularly in patients with a high risk for their development. |
topic |
postoperative cognitive dysfunction coronary artery bypass graft protein s100ß cerebrolysin |
url |
https://bulletin.tomsk.ru/jour/article/view/1980 |
work_keys_str_mv |
AT evlebedeva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT asgorokhov timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT edschastnyy timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT anrepin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT ggsimutkin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT evshishneva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT vaperchatkin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT aksurovtseva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT swinter timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT rskarpov timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft AT nabokhan timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft |
_version_ |
1721253275227914240 |